Abstract
Objectives: Despite the significant progress in developing small-molecule correctors, the mechanism of action (MoA) of these compounds needs to be further elucidated to achieve a more robust rescue of F508del-CFTR. Here, we investigated the efficacy and MoA of PTI-801, a newly developed F508del-CFTR corrector.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
